Following a record-breaking settlement against drugmaker Eli Lilly and its marketing practices, this series of reports explores the complex relationship between drug marketers, their regulators, and their targets: consumers. Pharmaceutical companies are grappling with the temptation of expanding their marketing reach into new outlets while trying to stay within the bounds of the law. How does this impact the patient at the end of the line?
See the contest questionnaire in which the reporter writes about how this story was written.